ab6982 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab6982 は 34 報の論文で使用されています。

  • Scherer J & Vallee RB Conformational changes in the adenovirus hexon subunit responsible for regulating cytoplasmic dynein recruitment. J Virol 89:1013-23 (2015). PubMed: 25355895
  • Tsou YL  et al. Recombinant adeno-vaccine expressing enterovirus 71-like particles against hand, foot, and mouth disease. PLoS Negl Trop Dis 9:e0003692 (2015). PubMed: 25855976
  • Jung R  et al. The Dual Nature of Nek9 in Adenovirus Replication. J Virol 90:1931-43 (2015). PubMed: 26676776
  • Martinez-Quintanilla J  et al. Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy. Mol Ther 23:108-18 (2015). PubMed: 25352242
  • Radko S  et al. Effects of Adenovirus Type 5 E1A Isoforms on Viral Replication in Arrested Human Cells. PLoS One 10:e0140124 (2015). PubMed: 26448631
  • Laborda E  et al. A pRb-responsive, RGD-modified, and Hyaluronidase-armed Canine Oncolytic Adenovirus for Application in Veterinary Oncology. Mol Ther N/A:N/A (2014). PubMed: 24448161
  • Di Paolo NC  et al. IL-1a and complement cooperate in triggering local neutrophilic inflammation in response to adenovirus and eliminating virus-containing cells. PLoS Pathog 10:e1004035 (2014). IHC . PubMed: 24651866
  • McFall ER  et al. A reduction in the human adenovirus virion size through use of a shortened fibre protein does not enhance muscle transduction following systemic or localised delivery in mice. Virology 468-470C:444-453 (2014). WB . PubMed: 25243333
  • Radko S  et al. Adenovirus E1A targets the DREF nuclear factor to regulate virus gene expression, DNA replication, and growth. J Virol 88:13469-81 (2014). ChIP ; Mouse . PubMed: 25210186
  • Inturi R  et al. Adenovirus precursor pVII protein stability is regulated by its propeptide sequence. PLoS One 8:e80617 (2013). WB . PubMed: 24260437
  • Bombardieri M  et al. Inducible tertiary lymphoid structures, autoimmunity, and exocrine dysfunction in a novel model of salivary gland inflammation in C57BL/6 mice. J Immunol 189:3767-76 (2012). IHC-Fr . PubMed: 22942425
  • Gomez-Gutierrez JG  et al. Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus. Virology 433:538-47 (2012). PubMed: 23021422
  • Rodriguez-Rocha H  et al. Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology 416:9-15 (2011). PubMed: 21575980
  • Ross PJ  et al. Assembly of helper-dependent adenovirus DNA into chromatin promotes efficient gene expression. J Virol 85:3950-8 (2011). PubMed: 21307207
  • Guedan S  et al. Hyaluronidase expression by an oncolytic adenovirus enhances its intratumoral spread and suppresses tumor growth. Mol Ther 18:1275-83 (2010). IHC-P, IHC-Fr . PubMed: 20442708
  • Soria C  et al. Heterochromatin silencing of p53 target genes by a small viral protein. Nature 466:1076-81 (2010). PubMed: 20740008
  • Willemsen RA  et al. Multi-component polymeric system for tumour cell-specific gene delivery using a universal bungarotoxin linker. Pharm Res 27:2274-82 (2010). ELISA . PubMed: 20300804
  • Ingemarsdotter CK  et al. Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer. Oncogene 29:6051-63 (2010). WB . PubMed: 20729921
  • Smith AC  et al. DNA genome size affects the stability of the adenovirus virion. J Virol 83:2025-8 (2009). WB . PubMed: 19036812
  • Di Paolo NC  et al. Virus binding to a plasma membrane receptor triggers interleukin-1 alpha-mediated proinflammatory macrophage response in vivo. Immunity 31:110-21 (2009). PubMed: 19576795
  • Gros A  et al. Bioselection of a gain of function mutation that enhances adenovirus 5 release and improves its antitumoral potency. Cancer Res 68:8928-37 (2008). PubMed: 18974137
  • O'Prey J  et al. The tumor antigen LRRC15 impedes adenoviral infection - implications for viral-based cancer therapy. J Virol : (2008). PubMed: 18385238
  • Peixoto C  et al. Towards purification of adenoviral vectors based on membrane technology. Biotechnol Prog 24:1290-6 (2008). WB . PubMed: 19194943
  • Miakotina OL  et al. Human adenovirus modulates surfactant phospholipid trafficking. Traffic 8:1765-77 (2007). PubMed: 17897321
  • Sebestyen Z  et al. An oncolytic adenovirus redirected with a tumor-specific T-cell receptor. Cancer Res 67:11309-16 (2007). PubMed: 18056457
  • Li X  et al. Fas ligand delivery by a prostate-restricted replicative adenovirus enhances safety and antitumor efficacy. Clin Cancer Res 13:5463-73 (2007). PubMed: 17875776
  • Cascallo M  et al. Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses. Hum Gene Ther 17:929-40 (2006). PubMed: 16972761
  • Majem M  et al. Control of E1A under an E2F-1 promoter insulated with the myotonic dystrophy locus insulator reduces the toxicity of oncolytic adenovirus Ad-Delta24RGD. Cancer Gene Ther 13:696-705 (2006). PubMed: 16498429
  • Subramanian T  et al. Genetic identification of adenovirus type 5 genes that influence viral spread. J Virol 80:2000-12 (2006). WB . PubMed: 16439556
  • Schepelmann S  et al. Systemic gene-directed enzyme prodrug therapy of hepatocellular carcinoma using a targeted adenovirus armed with carboxypeptidase G2. Cancer Res 65:5003-8 (2005). WB . PubMed: 15958540
  • Sargent KL  et al. Activation of adenoviral gene expression by protein IX is not required for efficient virus replication. J Virol 78:5032-7 (2004). WB . PubMed: 15113884
  • Campos SK  et al. Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. Mol Ther 9:942-54 (2004). PubMed: 15194061
  • Spector DJ  et al. Adenovirus type 5 DNA-protein complexes from formaldehyde cross-linked cells early after infection. Virology 312:204-12 (2003). PubMed: 12890633
  • Sprangers MC  et al. Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors. J Clin Microbiol 41:5046-52 (2003). PubMed: 14605137